1. Home
  2. ELUT vs BTMD Comparison

ELUT vs BTMD Comparison

Compare ELUT & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elutia Inc.

ELUT

Elutia Inc.

N/A

Current Price

$0.79

Market Cap

42.5M

Sector

Health Care

ML Signal

N/A

Logo Biote Corp.

BTMD

Biote Corp.

N/A

Current Price

$1.17

Market Cap

39.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ELUT
BTMD
Founded
2015
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.5M
39.0M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
ELUT
BTMD
Price
$0.79
$1.17
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $2.61
AVG Volume (30 Days)
23.5K
★ 140.1K
Earning Date
11-05-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
146.77
★ 722.22
EPS
N/A
★ N/A
Revenue
$12,293,000.00
★ $192,219,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$5.45
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.50
$1.15
52 Week High
$1.39
$3.26

Technical Indicators

Market Signals
Indicator
ELUT
BTMD
Relative Strength Index (RSI) N/A 31.58
Support Level N/A N/A
Resistance Level N/A $1.68
Average True Range (ATR) 0.00 0.07
MACD 0.00 0.00
Stochastic Oscillator 0.00 17.19

Price Performance

Historical Comparison
ELUT
BTMD

About ELUT Elutia Inc.

Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.

About BTMD Biote Corp.

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.

Share on Social Networks: